Table 1.
IHC results for αv integrin.
| Cases | Diagnosis | Main Lesion | Margins | |||||
|---|---|---|---|---|---|---|---|---|
| Spindle | Mononucleated Round |
Multinucleated Giant |
Endothelial | Fibroblasts | Fibrocytes | Inflammatory Cells | ||
| 1 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 2 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 3 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 4 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 5 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 6 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 7 | Fibrosarcoma | ++ (c) | \ | \ | +++ | ++ (c) | ± (c) | - |
| 8 | Pleomorphic sarcoma | ± (c) | +++ (m) | +++ (m) | +++ | ++ (c) | ± (c) | - |
| 9 | Pleomorphic sarcoma | ± (c) | +++ (m) | +++ (m) | +++ | ++ (c) | ± (c) | - |
| 10 | Pleomorphic sarcoma | ± (c) | ++ (m) | +++ (m) | +++ | ++ (c) | ± (c) | - |
| 11 | Osteosarcoma | + (c) | + (c) | + (c) | +++ | ++ (c) | ± (c) | - |
| 12 | Osteosarcoma | ++ (c) | ++ (c) | ++ (c); ± (m) | +++ | na | na | na |
| 13 | Osteosarcoma | + (c) | + (c) | + (c) | +++ | na | na | na |
| 14 | Osteosarcoma | ++ (c) | ++ (c) | ++ (c); ± (m) | +++ | na | na | na |
| 15 | Osteosarcoma | + (c) | + (c) | + (c) | +++ | na | na | na |
| 16 | Osteosarcoma | + (c) | + (c) | + (c) | +++ | na | na | na |
| 17 | Injection-site granuloma | \ | \ | \ | +++ | ++ (c) | ± (c) | - |
−: no staining; +: mild positive staining; ++: moderate positive staining +++: intense positive staining; c, cytoplasmic; m, membranous; na, not available.